1. Benzekri NA, Plaisy MK, Koffi JJ, Mensah E, et al.
   Food insecurity and cardiometabolic diseases among people with HIV in West Africa.
   AIDS 2026.
   


2. Chauhan L, Wu K, Tassiopoulos K, Rubin LH, et al.
   Effect of hospitalization on cognitive and physical function in people with HIV.
   AIDS 2026.
   


3. Cao Y, Zang S, Du J, Li S, et al.
   Genomic Characterization of Two Novel Human Immunodeficiency Virus-1 Recombinant Forms (CRF01_AE and B) in Men Who Have Sex with Men in Hebei, China.
   AIDS Res Hum Retroviruses 2026.
   


4. Moody K, Vanbellinghen MC, Nieuwkerk PT, Boyd A, et al.
   Health-related quality of life in well-treated people with HIV and comparators over an 8-year period: a longitudinal analysis from the prospective AGEhIV cohort study.
   Clin Infect Dis 2026.
   


5. Sabin CA.
   Does HIV infection continue to contribute to poorer health-related quality of life?
   Clin Infect Dis 2026.
   


6. Pugsley RA, Davis NL, Barbee LA.
   Is one all we really need? Reply to Lorenz et al regarding shorter duration of benzathine penicillin G therapy for late or unknown duration syphilis.
   Clin Infect Dis 2026.
   


7. Famiglietti AM, Drammeh S, Vo-Quang E, Dibba B, et al.
   Field performance and acceptability of the hepatitis B core-related antigen rapid diagnostic test (HBcrAg-RDT) for detecting high viral load among pregnant women in The Gambia (PROTECT-B).
   Clin Infect Dis 2026.
   


8. Sbarra AN, Stone W, Tetteh K, Ssewanyana I, et al.
   Assessing the effect of malaria exposure history on tetanus antibody waning rates among children in Jinja and Tororo Districts, Uganda.
   J Infect Dis 2026.
   


9. Dyer CEF, Molano M, Roberts JM, Yang T, et al.
   Causative Human Papillomavirus (HPV) Genotypes of Anal Cancers in Australian Cisgender Women.
   J Med Virol 2026;98:e70957.
   


10. Martres D, Montagne T, Pani S, Jeanne N, et al.
    Genotypic and phenotypic characteristics of CXCR4-using transmitted/founder HIV-1 envelope glycoproteins.
    J Virol 2026.
    


11. Shi H, Quan P, Hou Y, Wang H, et al.
    TRIP12 promotes HIV-1 replication and latency reactivation by stabilizing Tat via USP7-mediated deubiquitination.
    J Virol 2026.
    


12. Vinzant K, Cheshenko N, Pan H, Cutler R, et al.
    A cell-impermeable kinase inhibitor uncovers outside-in signaling pathways that promote HIV-1 infection.
    J Virol 2026.
    


13. Mendelson M, Brink A.
    Emerging beta-lactam and beta-lactamase inhibitor strategies for complicated urinary tract infections.
    Lancet 2026;407:1893-1895.
    


14. Rana AI, Castillo-Mancilla J, Landovitz RJ.
    Cabotegravir plus Rilpivirine for Persons with HIV and Adherence Challenges. Reply.
    N Engl J Med 2026;394:1963-1964.
    


15. Olalla J.
    Cabotegravir plus Rilpivirine for Persons with HIV and Adherence Challenges.
    N Engl J Med 2026;394:1963.
    


16. Hayden FG, Shinkai M, Clark TW, Luetkemeyer AF, et al.
    Ensitrelvir for Covid-19 Postexposure Prophylaxis in Household Contacts.
    N Engl J Med 2026;394:1905-1915.
    


17. Marin M, Raparti L, Leung J, Oliver SE, et al.
    Safety and Immunogenicity of Varicella Vaccination in Children and Adolescents Living With HIV: A Systematic Review.
    Pediatr Infect Dis J 2026.
    


18. Cohen J.
    Trump administration cuts CDC's key role in global program to stop HIV.
    Science 2026;392:680-681.
    


19. Nejadghaderi SA, Razai MS, Sharifi H, Harandi MF, et al.
    The US-Israeli war is driving a displacement crisis in Iran.
    BMJ 2026;393:s879.
    

Display articles in

• Abstract format